MétaCan
Menu
Back to cohort

The Great Controversy of Obstructive Sleep Apnea Treatment for Cardiovascular Risk Benefit: Advancing the Science Through Expert Consensus: An Official American Thoracic Society Workshop Report

2024· article· en· W4404183829 on OpenAlexafffund
Oren Cohen, Vaishnavi Kundel, Ferrán Barbé, Yüksel Peker, R. Doug McEvoy, Manuel Sánchez‐de‐la‐Torre, Daniel J. Gottlieb, T. Douglas Bradley, Mayte Suárez‐Fariñas, Andrey Zinchuk, Ali Azarbarzin, Atul Malhotra, Helena Schotland, David Gozal, Sanja Jelić, Alberto R. Ramos, Jennifer L. Martin, Sushmita Pamidi, Dayna A. Johnson, Reena Mehra, Virend K. Somers, Camilla M. Hoyos, Chandra L. Jackson, Carmela Alcántara, Martha E. Billings, Deepak L Bhatt, Sanjay R. Patel, Susan Redline, H. Klar Yaggi, Neomi Shah

Bibliographic record

VenueAnnals of the American Thoracic Society · 2024
Typearticle
Languageen
FieldMedicine
TopicObstructive Sleep Apnea Research
Canadian institutionsMcGill University Health CentreToronto General HospitalToronto Rehabilitation InstituteUniversity Health Network
FundersNational Center for Advancing Translational SciencesRespicardiaAgency for Healthcare Research and QualityIdorsia PharmaceuticalsAssistance publique-Hôpitaux de ParisDuke Clinical Research InstituteEisaiBelvoir Media GroupResMedNovo NordiskMyoKardiaRegado BiosciencesMedicines CompanyIronwood Pharmaceuticals, IncorporatedNational Heart, Lung, and Blood InstituteAmerican Academy of Sleep MedicineNational Institutes of HealthRegeneron PharmaceuticalsCanadian Institutes of Health ResearchCerebraJazz PharmaceuticalsBoston VA Research InstituteBoston Scientific CorporationUniversity of PittsburghHLS TherapeuticsAustralasian Sleep AssociationLivaNovaGlaxoSmithKlineNational Institute on AgingCSL BehringModernaPfizerUniversity of MiamiCleveland ClinicBristol-Myers SquibbEli Lilly and CompanyAmarin CorporationAstraZenecaAmerican College of Cardiology FoundationAmerican Heart AssociationAmerican Thoracic SocietyInstituto de Salud Carlos IIIAmgenAlnylam PharmaceuticalsU.S. Department of Veterans AffairsSanofi
KeywordsMedicineObstructive sleep apneaIntensive care medicineConsensus conferenceMEDLINESleep apneaCardiologyInternal medicineLaw

Abstract

fetched live from OpenAlex

The prevalence of obstructive sleep apnea (OSA) is on the rise, driven by various factors, including more sensitive diagnostic criteria, increased awareness, enhanced technology through at-home testing enabling easy and cost-effective diagnosis, and a growing incidence of comorbid conditions such as obesity. Treating symptomatic patients with OSA syndrome to enhance quality of life remains a cornerstone approach. However, there is a lack of consensus regarding treatment to improve cardiovascular disease (CVD) outcomes, particularly in light of overall negative results from several randomized controlled trials indicating no benefit of positive airway pressure therapy on primary and secondary CVD events. These randomized controlled trials were limited by suboptimal positive airway pressure adherence, use of composite CVD outcomes, and limited diversity and generalizability to sleep clinic patients. As such, this workshop assembled clinical experts, as well as researchers in basic and translational science, epidemiology, clinical trials, and population health, to discuss the current state and future research directions to guide personalized therapeutic strategies and future research directions in OSA. There was overall consensus among workshop participants that OSA represents a heterogeneous disease with variable endotypes and phenotypes and heterogeneous responses to treatment. Future research should prioritize using multimodal therapeutic approaches within innovative and adaptive trial designs, focusing on specific subgroups of patients with OSA hypothesized to benefit from a CVD perspective. Future work should also be inclusive of diverse populations and consider the life course of OSA to better comprehend treatment strategies that can address the disproportionate impact of OSA on racially minoritized groups. Furthermore, a more holistic approach to sleep must be adopted to include broader assessments of symptoms, sleep duration, and comorbid sleep and circadian disorders. Finally, it is imperative to establish a sleep research consortium dedicated to collecting raw data and biospecimens categorized by OSA subtypes. This will facilitate mechanistic determinations, foster collaborative research, and help bolster the pipeline of early-career researchers.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.138
metaresearch head score (Gemma)0.145
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.138
Threshold uncertainty score0.730

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1380.145
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0020.005
Bibliometrics0.0030.002
Science and technology studies0.0050.005
Scholarly communication0.0120.010
Open science0.0070.015
Research integrity0.0190.035
Insufficient payload (model declined to judge)0.0060.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.079
GPT teacher head0.427
Teacher spread0.348 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations22
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueAnnals of the American Thoracic SocietySame topicObstructive Sleep Apnea ResearchFrench-language works237,207